» Articles » PMID: 11607932

Chemical Genomics: Functional Analysis of Orphan Nuclear Receptors in the Regulation of Bile Acid Metabolism

Overview
Journal Med Res Rev
Publisher Wiley
Date 2001 Oct 19
PMID 11607932
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Chemical genomics is the name we have given to the analysis of gene function through use of small molecule chemical tools. Orphan nuclear receptors are ideally suited to this technique of functional analysis, since their activity as transcription factors is regulated by small hydrophobic ligands. GW4064 is a potent and selective nonsteroidal ligand for the nuclear bile acid receptor FXR (NR1H4). Using GW4064 as a chemical tool, we have identified genes regulated by FXR in the liver, including those involved in bile acid synthesis and transport. We have also discovered that PXR (NR1I2) is a lithocholic acid receptor that controls the biosynthesis and metabolism of bile acids. Together FXR and PXR cooperate to control biliary and urinary bile acid excretion. These functions suggest that potent PXR and FXR ligands may offer a new approach to the treatment of cholestatic liver disease.

Citing Articles

Host metabolism balances microbial regulation of bile acid signalling.

Won T, Arifuzzaman M, Parkhurst C, Miranda I, Zhang B, Hu E Nature. 2025; 638(8049):216-224.

PMID: 39779854 PMC: 11886927. DOI: 10.1038/s41586-024-08379-9.


Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation.

Alonso-Pena M, Espinosa-Escudero R, Hermanns H, Briz O, Herranz J, Garcia-Ruiz C Cells. 2022; 11(24).

PMID: 36552746 PMC: 9777420. DOI: 10.3390/cells11243983.


Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet.

Schlezinger J, Puckett H, Oliver J, Nielsen G, Heiger-Bernays W, Webster T Toxicol Appl Pharmacol. 2020; 405:115204.

PMID: 32822737 PMC: 7503133. DOI: 10.1016/j.taap.2020.115204.


Unexplored therapeutic opportunities in the human genome.

Oprea T, Bologa C, Brunak S, Campbell A, Gan G, Gaulton A Nat Rev Drug Discov. 2018; 17(5):317-332.

PMID: 29472638 PMC: 6339563. DOI: 10.1038/nrd.2018.14.


The Farnesoid X Receptor: Good for BAD.

Keely S, Walters J Cell Mol Gastroenterol Hepatol. 2017; 2(6):725-732.

PMID: 28174746 PMC: 5247348. DOI: 10.1016/j.jcmgh.2016.08.004.